SEARCH

SEARCH BY CITATION

References

  • BANOVAC, K. & DE FORTEZA, R. (1992). The effect of mast cell chymase on extracellular matrix: studies in autoimmune thyroiditis and in cultured thyroid cells. Int. Arch. Allergy Immunol., 99, 141149.
  • CAUGHEY, G.H., LEIDIG, F., VIRO, N.F. & NADEL, J.A. (1988). Substance P and vasoactive intestinal peptide degradation by mast cell tryptase and chymase. J. Pharmacol. Exp. Ther., 244, 133137.
  • CAUGHEY, G.H., RAYMOND, W.W. & WOLTERS, P.J. (2000). Angiotensin II generation by mast cell alpha- and beta-chymases. Biochim. Biophys. Acta, 1480, 245257.
  • CLAMAN, H.N. (1989). Mast cell changes in a case of rapidly progressive scleroderma – ultrastructural analysis. J. Invest. Dermatol., 92, 290295.
  • CLAMAN, H.N. (1993). Mast cells and fibrosis: hints from graft-versus-host disease and scleroderma. In: The Mast Cell in Health and Disease. Lung Biology in Health and Disease, eds. Kaliner, M.A. & Metcalfe, D.D. Vol. 62, pp. 653667. New York: Marcel Dekker.
  • ENERBACK, L. & LOWHAGEN, G.B. (1979). Long term increase of mucosal mast cells in the rat induced by administration of compound 48/80. Cell Tissue Res., 198, 209215.
  • EVERETT, E.T., PABLOS, J.L., HARLEY, R.A., LEROY, E.C. & NORRIS, J.S. (1995). The role of mast cells in the development of skin fibrosis in tight-skin mutant mice. Comp. Biochem. Physiol. A, 110, 159165.
  • FANG, K.C., WOLTERS, P.J., STEINHOFF, M., BIDGOL, A., BLOUNT, J.L. & CAUGHEY, G.H. (1999). Mast cell expression of gelatinases A and B is regulated by kit ligand and TGF-beta. J. Immunol., 162, 55285535.
  • FUKAMI, H., IMAJO, S., ITO, A., KAKUTANI, S., SHIBATA, H., SUMIDA, M., TANAKA, T., NIWATA, S., SAITOH, M., KISO, Y., MIYAZAKI, M., OKUNISHI, H., URATA, H. & ARAKAWA, K. (2000). Substituted 3-phenylsulfonylquinazoline-2,4-dione derivatives as novel nonpeptide inhibitors of human heart chymase. Drug Des. Discov., 17, 6984.
  • GABRIELLI, A., DI LORETO, C., TABORRO, R., CANDELA, M., SAMBO, P., NITTI, C., DANIELI, M.G., DELUSTRO, F., DASCH, J.R. & DANIELI, G. (1993). Immunohistochemical localization of intracellular and extracellular associated TGF beta in the skin of patients with systemic sclerosis (scleroderma) and primary Raynaud's phenomenon. Clin. Immunol. Immunopathol., 68, 340349.
  • GREEN, M.C., SWEET, H.O. & BUNKER, L.E. (1976). Tight-skin, a new mutation of the mouse causing excessive growth of connective tissue and skeleton. Am. J. Pathol., 82, 493512.
  • GRUBER, B.L. & KAUFMAN, L.D. (1990). Ketotifen-induced remission in progressive early diffuse scleroderma: evidence for the role of mast cells in disease pathogenesis. Am. J. Med., 89, 392395.
  • HAWKINS, R.A., CLAMAN, H.N., CLARK, R.A. & STEIGERWALD, J.C. (1985). Increased dermal mast cell populations in progressive systemic sclerosis: a link in chronic fibrosis? Ann. Intern. Med., 102, 182186.
  • HE, S., GACA, M.D., MCEUEN, A.R. & WALLS, A.F. (1999). Inhibitors of chymase as mast cell-stabilizing agents: contribution of chymase in the activation of human mast cells. J. Pharmacol. Exp. Ther., 291, 517523.
  • HUANG, R.Y., BLOM, T. & HELLMAN, L. (1991). Cloning and structural analysis of MMCP-1, MMCP-4 and MMCP-5, three mouse mast cell-specific serine proteases. Eur. J. Immunol., 21, 16111621.
  • JIMENEZ, S.A. & CHRISTNER, P. (1994). Animal models of systemic sclerosis. Clin. Dermatol., 12, 425436.
  • KAKIZOE, E., SHIOTA, N., TANABE, Y., SHIMOURA, K., KOBAYASHI, Y. & OKUNISHI, H. (2001). Isoform-selective upregulation of mast cell chymase in the development of skin fibrosis in scleroderma model mice. J. Invest. Dermatol., 116, 118123.
  • KAWAKAMI, T., IHN, H., XU, W., SMITH, E., LEROY, C. & TROJANOWSKA, M. (1998). Increased expression of TGF-beta receptors by scleroderma fibroblasts: evidence for contribution of autocrine TGF-beta signaling to scleroderma phenotype. J. Invest, Dermatol., 110, 4751.
  • LEVI-SCHAFFER, F. (1995). Mast cell/fibroblast interactions in health and disease. In: Human Basophils and Mast Cells: Biological Aspects Chemical Immunology, ed. Marone, G. Vol. 61, pp. 165185. Basel: Karger.
  • LINDSTEDT, K.A., WANG, Y., SHIOTA, N., SAARINEN, J., HYYTIAINEN, M., KOKKONEN, J.O., KESKI-OJA, J. & KOVANEN, P.T. (2001). Activation of paracrine TGF-beta1 signaling upon stimulation and degranulation of rat serosal mast cells: a novel function for chymase. FASEB J., 15, 13771388.
  • LONGLEY, B.J., TYRRELL, L., MA, Y., WILLIAMS, D.A., HALABAN, R., LANGLEY, K., LU, H.S. & SCHECHTER, N.M. (1997). Chymase cleavage of stem cell factor yields a bioactive, soluble product. Proc. Natl. Acad. Sci. U.S.A., 94, 90179021.
  • MATSUMOTO, T., WADA, A., TSUTAMOTO, T., OHNISHI, M., ISONO, T. & KINOSHITA, M. (2003). Chymase inhibition prevents cardiac fibrosis and improves diastolic dysfunction in the progression of heart failure. Circulation, 107, 25552558.
  • MAYES, M.D., LACEY Jr, J.V., BEEBE-DIMMER, J., GILLESPIE, B.W., COOPER, B., LAING, T.J. & SCHOTTENFELD, D. (2003). Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum., 48, 22462255.
  • MENTON, D.N., HESS, R.A., LICHTENSTEIN, J.R. & EISEN, A. (1978). The structure and tensile properties of the skin of tight-skin (Tsk) mutant mice. J. Invest. Dermatol., 70, 410.
  • MIZUTANI, H., SCHECHTER, N., LAZARUS, G., BLACK, R.A. & KUPPER, T.S. (1991). Rapid and specific conversion of precursor interleukin 1 beta (IL-1 beta) to an active IL-1 species by human mast cell chymase. J. Exp. Med., 174, 821825.
  • NISHIKORI, Y., KAKIZOE, E., KOBAYASHI, Y., SHIMOURA, K., OKUNISHI, H. & DEKIO, S. (1998). Skin mast cell promotion of matrix remodeling in burn wound healing in mice: relevance of chymase. Arch. Dermatol. Res., 290, 553560.
  • NISHIOKA, K., KOBAYASHI, Y., KATAYAMA, I. & TAKIJIRI, C. (1987). Mast cell numbers in diffuse scleroderma. Arch. Dermatol., 123, 205208.
  • PAANANEN, K. & KOVANEN, P.T. (1994). Proteolysis and fusion of low density lipoprotein particles independently strengthen their binding to exocytosed mast cell granules. J. Biol. Chem., 269, 20232031.
  • REILLY, C.F., TEWKSBURY, D.A., SCHECHTER, N.M. & TRAVIS, J. (1982). Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cell proteinases. J. Biol. Chem., 257, 86198622.
  • SAARINEN, J., KALKKINEN, N., WELGUS, H.G. & KOVANEN, P.T. (1994). Activation of human interstitial procollagenase through direct cleavage of the Leu83-Thr84 bond by mast cell chymase. J. Biol. Chem., 269, 1813418140.
  • SCHICK, B., AUSTEN, K.F. & SCHWARTZ, L.B. (1984). Activation of rat serosal mast cells by chymase, an endogenous secretory granule protease. J. Immunol., 132, 25712577.
  • SEIBOLD, J.R., GIORNO, R.C. & CLAMAN, H.N. (1990). Dermal mast cell degranulation in systemic sclerosis. Arthritis Rheum., 33, 17021709.
  • SHIOTA, N., FUKAMIZU, A., OKUNISHI, H., TAKAI, S., MURAKAMI, K. & MIYAZAKI, M. (1998). Cloning of the gene and cDNA for hamster chymase 2, and expression of chymase 1, chymase 2 and angiotensin-converting enzyme in the terminal stage of cardiomyopathic hearts. Biochem. J., 333, 417424.
  • SHIOTA, N., FUKAMIZU, A., TAKAI, S., OKUNISHI, H., MURAKAMI, K. & MIYAZAKI, M. (1997). Activation of angiotensin II-forming chymase in the cardiomyopathic hamster heart. J. Hypertens., 15, 431440.
  • SHIOTA, N., OKUNISHI, H., FUKAMIZU, A., SAKONJO, H., KIKUMORI, M., NISHIMURA, T., NAKAGAWA, T., MURAKAMI, K. & MIYAZAKI, M. (1993). Activation of two angiotensin-generating systems in the balloon-injured artery. FEBS Lett., 323, 239242.
  • SHIOTA, N., OKUNISHI, H., TAKAI, S., MIKOSHIBA, I., SAKONJO, H., SHIBATA, N. & MIYAZAKI, M. (1999). Tranilast suppresses vascular chymase expression and neointima formation in balloon-injured dog carotid artery. Circulation, 99, 10841090.
  • SPRINGMAN, E.B. & SERAFIN, W.E. (1995). Secretory endo- and exopeptidases of mouse mast cells: structure, genetics, and regulation of expression. In: Mast Cell Proteases in Immunology and Biology. Clinical Allergy and Immunology, ed. Caughey, G.H. Vol. 6, pp. 169201. New York: Marcel Dekker.
  • TAIPALE, J., LOHI, J., SAARINEN, J., KOVANEN, P.T. & KESKI-OJA, J. (1995). Human mast cell chymase and leukocyte elastase release latent transforming growth factor-beta 1 from the extracellular matrix of cultured human epithelial and endothelial cells. J. Biol. Chem., 270, 46894696.
  • TOMIMORI, Y., MUTO, T., FUKAMI, H., SAITO, K., HORIKAWA, C., TSURUOKA, N., YAMASHIRO, K., SAITO, M., SUGIURA, N., SUMIDA, M., KAKUTANI, S. & FUKUDA, Y. (2002). Mast cell chymase regulates dermal mast cell number in mice. Biochem. Biophys. Res. Commun., 290, 14781482.
  • VARTIO, T., SEPPA, H. & VAHERI, A. (1981). Susceptibility of soluble and matrix fibronectins to degradation by tissue proteinases, mast cell chymase and cathepsin G. J. Biol. Chem., 256, 471477.
  • WALKER, M., HARLEY, R., MAIZE, J., DELUSTRO, F. & LEROY, E.C. (1985). Mast cells and their degranulation in the Tsk mouse model of scleroderma. Proc. Soc. Exp. Biol. Med., 180, 323328.
  • WALKER, M.A., HARLEY, R.A. & LEROY, E.C. (1987). Inhibition of fibrosis in TSK mice by blocking mast cell degranulation. J. Rheumatol., 14, 299301.
  • WATANABE, N., TOMIMORI, Y., SAITO, K., MIURA, K., WADA, A., TSUDZUKI, M. & FUKUDA, Y. (2002). Chymase inhibitor improves dermatitis in NC/Nga mice. Int. Arch. Allergy Immunol., 128, 229234.
  • WYPIJ, D.M., NICHOLS, J.S., NOVAK, P.J., STACY, D.L., BERMAN, J. & WISEMAN, J.S. (1992). Role of mast cell chymase in the extracellular processing of big-endothelin-1 to endothelin-1 in the perfused rat lung. Biochem. Pharmacol., 43, 845853.